Another report illustrated a comparable anti-diabetic potential of UC-MSCs and amniotic membrane (AM)-derived MSCs in T2D db/db mice and that was ascribed to the improved glycolipid metabolism, increased insulin sensitivity, and decreased inflammation in the liver of db/db mice [48]. The gene discussed is INS; the disease is type 2 diabetes mellitus.